Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Andrew D Skol1, Laura J Scott, Gonçalo R Abecasis

  • 1Department of Biostatistics and Center for Statistical Genetics, University of Michigan, 1420 Washington Heights, Ann Arbor, Michigan 48109-2029, USA.

Nature Genetics
|January 18, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare protein-coding variation and the genetic architecture of height in >1.4 million individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Population-scale repeat expansions elucidate disease risk and brain atrophy.

Nature·2026
Same author

Recognition of a Critical Functional Domain and Improved <i>PHOX2B</i> Missense Variant Interpretation by Utilization of In Silico Prediction Tools.

Human mutation·2026
Same author

A resource of "bottom-line" variant associations for 1,281 complex traits by integrating data across published genome-wide association studies.

Research square·2026
Same author

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Blood·2026
Same author

Variant Classification Using Proteomics-Informed Large Language Models Increases Power of Rare Variant Association Studies and Enhances Target Discovery.

Genetic epidemiology·2025

Jointly analyzing data from both stages of genome-wide association studies (GWAS) significantly increases the power to detect genetic associations compared to traditional methods. This approach is particularly effective when a substantial portion of samples and markers are used in the initial stage.

Area of Science:

  • Human Genetics
  • Statistical Genomics
  • Disease Association Studies

Background:

  • Genome-wide association studies (GWAS) aim to identify common genetic variants linked to human diseases.
  • The high cost of GWAS often necessitates a two-stage design involving initial genotyping and subsequent follow-up.
  • Traditional analysis treats the second stage as replication, focusing solely on its statistically significant findings.

Purpose of the Study:

  • To evaluate the effectiveness of jointly analyzing data from both stages of a two-stage GWAS.
  • To compare the power of joint analysis versus traditional stage-specific analysis for detecting genetic associations.
  • To provide recommendations for optimal sample and marker proportions in staged GWAS designs.

Main Methods:

  • Statistical analysis of data from two-stage genome-wide association studies.

Related Experiment Videos

  • Comparison of power between joint analysis and stage 2 replication analysis.
  • Investigation of the impact of differing effect sizes between stages.
  • Main Results:

    • Jointly analyzing data from both stages consistently increases statistical power to detect genetic associations.
    • This increased power is achieved even when using more stringent significance thresholds and when effect sizes vary between stages.
    • The benefit of joint analysis is more pronounced with larger sample proportions in stage 1 (>=0.30) and marker follow-up (>=0.01).

    Conclusions:

    • Joint analysis is a superior strategy for two-stage genome-wide association studies.
    • This method enhances the detection of disease-predisposing genetic variants.
    • Recommendations are made for optimizing staged GWAS designs to maximize analytical power.